TrustCo Bank Corp NY (NASDAQ:TRST) Q1 2025 Earnings Conference Call April 22, 2025 9:00 AM ET Company Participants Robert McCormick - Chairman, President & CEO Michael Ozimek - EVP & CFO Kevin Curley - EVP, Retail Banking Conference Call Participants Ian Lapey - Gabelli Funds Operator Good day, and welcome to TrustCo Bank Corp Earnings Call and Webcast. All participant will be on listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator In ...

Financial Data and Key Metrics Changes - In Q1 2025, consolidated revenues were $2.65 billion, up 12.1% year-over-year, with organic revenues growing by 2.4% [28] - Reported operating income was $346 million, representing 13% of revenues, compared to $300 million or 12.7% of revenues last year [31] - Reported EPS was $1.94, compared to $1.72 a year ago, while adjusted EPS was $2.21 versus $2.04 the prior year [32] Business Line Data and Key Metrics Changes - Revenues for Diagnostic Information Services increased by 12.7% year-over-year, driven by acquisitions and growth in physician and hospital channels [29] - Total volume measured by requisitions increased by 12.4% year-over-year, with organic volume down by 0.9% [29] - Revenue per requisition was up 0.3% year-over-year, with organic revenue per requisition increasing by 3.6% [30] Market Data and Key Metrics Changes - The physician channel saw revenue growth in the high teens, largely driven by acquisitions, with organic revenue growth in the mid-single digits [13] - Advanced diagnostics in key clinical areas such as cardiometabolic and autoimmune testing grew at double-digit rates [20] - The company expanded its health plan partnerships, contributing to revenue growth through access to new geographies [14] Company Strategy and Development Direction - The company’s growth strategy focuses on delivering solutions for core clinical customers and expanding into consumer-initiated testing, life sciences, and data analytics [11] - Automation, robotics, and AI are being deployed to improve quality and productivity [12] - The company aims to expand in high-growth areas and enhance its online consumer-initiated test platform [18] Management's Comments on Operating Environment and Future Outlook - Management reaffirmed revenue and adjusted EPS guidance for the full year 2025, expecting revenues between $10.7 billion and $10.85 billion [33] - The company anticipates approximately 3% organic revenue growth, with the remainder from acquisitions [35] - Management expressed optimism regarding the impact of recent regulatory changes and ongoing investments in quality management processes [10][36] Other Important Information - The company is collaborating with Google Cloud to streamline data management and enhance customer and employee experiences through GenAI [26] - The recent court ruling vacating the FDA rule on laboratory developed tests is expected to reduce regulatory costs and improve access to innovative testing services [9][10] Q&A Session Summary Question: Organic volume trends and expectations for the rest of the year - Management noted that organic volume was down 90 basis points but would have increased by 160 basis points when adjusting for leap year and weather impacts [42][43] Question: Exposure to tariffs and supply costs - Management indicated that less than 1% of their $2 billion supply spend is sourced directly from China, with most supplies manufactured in the U.S. [48][50] Question: Impact of strikes at LifeLabs - Management clarified that the strike is limited to British Columbia and is being managed effectively, with progress expected in the next 30 to 45 days [56][57] Question: Margin expectations for Q2 - Management expects Q2 to be the strongest quarter, with operating margins anticipated to grow compared to the previous year [60][62] Question: Opportunities in hospital lab management due to tariffs - Management indicated that the funnel of opportunities in collaborative lab services remains robust, with ongoing negotiations with several institutions [72] Question: Updates on Haystack and reimbursement submissions - Management reported positive progress with Haystack, with ongoing efforts to establish reimbursement processes [95][96] Question: Financial benefits from collaboration with Google Cloud - Management highlighted that moving data to the cloud will improve efficiency in data analytics and enhance customer and employee experiences [102][104] Question: Regulatory updates and potential cuts to Medicare and Medicaid - Management expressed optimism regarding Medicare Advantage rate increases and is closely monitoring potential Medicaid cuts, which represent about 8% of their business [107][110]

Financial Data and Key Metrics Changes - Total company revenue for Q1 2025 was $5.4 billion, a decrease of 7% compared to Q1 2024 [28] - Adjusted operating margin was 14.5% [28] - Cash flow from operations was $377 million, and free cash flow was $124 million [7][35] - Reported net income per diluted share was $0.24, while adjusted net income per diluted share was $0.60 [27] Business Line Data and Key Metrics Changes - Completion and Production (C&P) division revenue was $3.1 billion, down 8% year-over-year, with operating income of $531 million, a decrease of 23% [29] - Drilling and Evaluation (D&E) division revenue was $2.3 billion, down 6% year-over-year, with operating income of $352 million, a decrease of 12% [30] - International revenue was $3.2 billion, a decrease of 2% year-over-year, while North America revenue was $2.2 billion, a decrease of 12% year-over-year [6][32] Market Data and Key Metrics Changes - Europe Africa revenue increased by 6% year-over-year to $775 million, driven by improved activity in Norway and Namibia [31] - Middle East Asia revenue also increased by 6% year-over-year to $1.5 billion, attributed to higher activity in Kuwait and Saudi Arabia [32] - Latin America revenue decreased by 19% year-over-year to $896 million, primarily due to lower activity in Mexico [32] Company Strategy and Development Direction - The company emphasizes technology, collaboration, and service quality as core to its competitive advantage [10][14] - Halliburton aims to maximize value in North America while driving growth engines internationally, particularly in unconventional, artificial lift, intervention, and directional drilling [15][19] - The company is focused on maintaining a strong position in the offshore market, leveraging advanced technologies for integrated projects [128][130] Management's Comments on Operating Environment and Future Outlook - Management noted increased uncertainty in the market due to trade dynamics and OPEC production, but remains confident in the fundamental role of oil and gas in global economic growth [8][11] - The outlook for international revenue is expected to be flat to slightly down, with strong tender activity and contract awards providing visibility [12][39] - Management anticipates solid free cash flow generation in 2025, with plans to return at least $1.6 billion to shareholders through buybacks and dividends [25] Other Important Information - The company recognized a pre-tax charge of $356 million related to severance costs and asset impairments [28] - Capital expenditures for Q1 were $302 million, with expectations of approximately 6% of revenue for the full year [35] Q&A Session Summary Question: North American activity outlook amidst commodity price volatility - Management indicated that customers are currently evaluating their activity scenarios, with a focus on production impacts from any potential declines in activity [45][48] Question: Trajectory of operations in Mexico - Management expressed that recovery in Mexico is uncertain, with expectations of a tough environment for the foreseeable future [51][52] Question: Growth prospects in Saudi Arabia - Management expects growth in Saudi Arabia, particularly in the Jafurah area, and highlighted opportunities in unconventional and artificial lift markets [57][58] Question: Margin progression expectations - Management provided guidance for Q2 margins, indicating specific impacts from tariffs and mobilization costs, with expectations for improvement in the second half of the year [60][66] Question: Impact of tariffs on business - Management noted a $0.02 to $0.03 impact per share from tariffs, with ongoing efforts to mitigate these effects through a diversified supply chain [94][96] Question: International spending outlook - Management highlighted solid growth in Norway and Brazil, with expectations for increased activity in Europe and Africa in the second half of the year [75][102]

Financial Data and Key Metrics Changes - In Q1 2025, GAAP diluted earnings per share was $9.61, and adjusted diluted earnings per share was $11.97, reflecting year-over-year growth of more than 10% [25] - Operating revenue for the quarter was $48.8 billion, an increase of over 15%, driven by higher premium yields in the health benefits segment and growth in Medicare Advantage and individual ACA membership [26] - The consolidated benefit expense ratio was 86.4%, an increase of 80 basis points year over year, primarily due to higher cost trends in the Medicaid business [27] Business Line Data and Key Metrics Changes - Medicaid business is making progress on rate alignment, with April adjustments coming in as expected [16] - Medicare Advantage performance was consistent with expectations, with strong retention and targeted growth [17] - Health benefits operating gain was $2.2 billion, slightly declining due to higher Medicaid costs, while Calon's operating gain grew 34% to $1.1 billion [29] Market Data and Key Metrics Changes - Individual ACA membership grew approximately 11% sequentially, but a moderation in membership is anticipated in Q2 due to lower effectuation rates [25][56] - The company is expanding into three new states to support broader strategy for coordinated ACA and Medicaid coverage [19] Company Strategy and Development Direction - The company is focused on transforming healthcare experiences to be simpler, more affordable, and more human, with sustained investments in patient advocacy solutions and digital platforms [9][10] - Expansion of value-based oncology care model to Medicare Advantage is planned, following success in the commercial sector [12] - Carillon continues to be a strategic growth engine, significantly expanding relationships with external payers [20] Management Comments on Operating Environment and Future Outlook - Management expressed confidence in the long-term outlook for Medicare Advantage, emphasizing strong retention and disciplined growth [17] - Elevated Medicare costs are manageable, with consistent tracking of claims data to identify emerging patterns [39][41] - The company remains disciplined in its approach to benefit design and risk management, ensuring alignment with healthcare needs [129] Other Important Information - The company was named to Fortune's 100 Best Companies to Work For and recognized as one of America's most innovative companies [22] - Operating cash flow totaled $1 billion, with expectations for approximately $8 billion for the year remaining unchanged [32] Q&A Session Summary Question: Medicare Advantage trends and IRA impact - Management indicated that Medicare costs remain elevated but manageable, with no material changes in expectations [39][41] Question: Carillon Services growth and cross-sales - Carillon Services experienced over 60% growth, with strong internal and external expansion [47] Question: Effectuation rates and membership attrition - Membership attrition is projected in the mid-single digit percent range in early Q2, with stabilization expected thereafter [56] Question: Medicaid MLR margin trends - Medicaid trends remain elevated but decelerated as expected, with improvements anticipated in the latter half of the year [117] Question: Part D changes and utilization behavior - Management is comfortable with the mix of Medicare Advantage membership and has not observed substantial variations in utilization [140]

Home Bancorp (HBCP) Q1 2025 Earnings Call April 22, 2025 11:30 AM ET Company Participants David Kirkley - Senior EVP & CFOJohn Bordelon - Chairman, President & CEOJoseph Yanchunis - Senior Equity Research AssociateChristopher Marinac - Director of ResearchStephen Scouten - Managing Director Operator morning, ladies and gentlemen, and welcome to the Home Bancorp's First Quarter twenty twenty five Earnings Conference Call. Please note this event is being recorded. I would now like to turn the conference over ...

Home Bancorp, Inc. (HBCP) Q1 2025 Earnings Conference Call April 22, 2025 11:30 AM ET Company Participants Operator - Conference Call OperatorJohn Bardelon - Chairman, President and CEODavid Kirke - Chief Financial Officer Conference Call Participants Chris Marinette - Analyst, G. MontgomeryJason Sautin - Analyst, HyperTanzer Operator Thank you, ladies and gentlemen, and welcome to the home band for its first quarter 2025 Ernie's Conference call. All participants will be in listen-only mode. Should you need ...

Financial Data and Key Metrics Changes - The company achieved 8% organic sales growth and 120 basis points of segment margin expansion, with strong contributions from each business segment [7][34] - Adjusted sales reached $20.3 billion, up 5% overall and 8% organically, with adjusted earnings per share of $1.47, reflecting a 10% increase from the prior year [34][35] - Free cash flow improved by over $900 million compared to the previous year, totaling $792 million in the quarter [7][35] Business Line Data and Key Metrics Changes - Commercial aftermarket sales increased by 21%, while commercial OE sales rose by 3% and defense sales grew by 4% [8] - Collins reported sales of $7.2 billion, up 8% adjusted and 9% organically, driven by commercial aftermarket and defense strength [37] - Pratt & Whitney's sales reached $7.4 billion, up 14% on both adjusted and organic bases, with commercial aftermarket sales up 28% [40] - Raytheon experienced a 5% decline in adjusted sales to $6.3 billion, but organic sales were up 2% due to higher volume in land and air defense systems [42] Market Data and Key Metrics Changes - The company exited the quarter with a backlog of $217 billion, an 8% year-over-year increase, including $125 billion in commercial orders and $92 billion in defense awards [28] - The European Union has proposed an additional $850 billion in defense spending over the next four years, which aligns with the company's core capabilities [30] Company Strategy and Development Direction - The company is focused on executing commitments, innovating for future growth, and leveraging its breadth and scale [31] - Continued investment in the U.S. industrial base is planned, with nearly $10 billion invested over the last five years and an additional $2 billion planned for this year [17][18] - The company is adapting to a dynamic operating environment, particularly regarding tariffs and supply chain management [15][27] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's positioning within key end markets, citing strong product portfolios and a robust backlog [28][46] - The ongoing global trade environment is being closely monitored, with potential tariff impacts not yet included in the current outlook [21][27] - Management remains optimistic about defense spending and the demand for integrated air and missile defense systems [30][31] Other Important Information - The company is making significant progress on future franchises, including the GTF Advantage and the LTAMS program, which are expected to enhance market competitiveness [12][14] - The company has seen improvements in supply chain stability, with overdue line items down over 20% year-over-year [10][70] Q&A Session Summary Question: Opportunities from European rearmament efforts - Management sees significant opportunities for Raytheon due to increased defense spending in Europe, with expectations of a book-to-bill ratio of 1.0 or more [53][56] Question: Clarification on tariff impacts - The $850 million estimate is net of mitigations, and the company has strategies in place to manage costs and pricing in response to tariffs [61][90] Question: Supply chain disruptions and China strategy - Management is focused on maintaining supply chain stability and developing multiple sourcing strategies globally, particularly in light of tariff impacts [70][74] Question: NGAP program progress - The company received a $550 million award for the NGAP program and is pleased with the testing progress and customer feedback [78] Question: Operational impacts from SPS fire - Management is optimistic about mitigating impacts from the SPS fire through collaboration with alternative suppliers [82] Question: Procurement reform implications - The company supports efforts to streamline procurement processes, which could enhance contract award timelines and reduce risks [114]

Financial Data and Key Metrics Changes - The company's Q1 2025 revenue was $5.7 billion, with core revenue flat year-over-year [15] - Gross profit margin increased by 100 basis points to 61.2%, while adjusted operating profit margin decreased by 50 basis points to 29.6% [16] - Adjusted diluted net earnings per share were $1.88, and free cash flow generated was $1.1 billion, resulting in a free cash flow to net income conversion ratio of over 110% [17] Business Line Data and Key Metrics Changes - In the biotechnology segment, core revenue increased by 7%, driven by high single-digit growth in bioprocessing [21] - Life sciences segment core revenue decreased by 4%, with low single-digit declines in instrument businesses [25] - Diagnostics segment core revenue declined by 1.5%, with clinical diagnostics essentially flat outside of China [27] Market Data and Key Metrics Changes - Core revenues in developed markets saw a slight decline, with low single-digit decreases in North America and low single-digit increases in Western Europe [15] - High-growth markets experienced low single-digit growth, with solid performance outside of China offsetting a high single-digit decline within China [15] - The decline in China was attributed to volume-based procurement and reimbursement changes impacting diagnostics businesses [16] Company Strategy and Development Direction - The company is focused on delivering long-term value for shareholders while navigating a dynamic macro environment [10][13] - Investments of approximately $2 billion since 2020 have been made to expand capacity and ensure supply security [23] - The company aims to leverage the Danaher Business System (DBS) to manage supply chains and drive process improvements [12][35] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's positioning despite geopolitical and trade tensions, emphasizing the strength of their recurring revenue model [11][10] - For 2025, the company expects core revenue growth of approximately 3%, with adjusted diluted EPS guidance in the range of $7.60 to $7.75 [33] - The company anticipates stable end market demand for the remainder of 2025, with a focus on addressing tariff impacts through various levers [32][46] Other Important Information - The company launched several impactful new products in Q1 2025, reinforcing competitive advantages and aiding customer efficiency [18][20] - The company is prepared to address potential tariff impacts through supply chain adjustments and cost actions [50][51] Q&A Session Summary Question: Insights on bioprocessing order strength - Management noted strong orders and revenue performance in bioprocessing, expecting high single-digit core revenue growth for 2025, driven primarily by consumables [43][44] Question: Tariff impacts and offsets - Management indicated that the estimated tariff impact could be around $350 million, but they are well-positioned to offset these headwinds through various strategies [48][49] Question: Long-term growth outlook in China - Management believes China will remain a significant diagnostic market, with pricing adjustments aligning closer to global standards [71] Question: Life sciences performance and guidance - Management acknowledged a softening in U.S. academic and government demand, leading to a revised flat growth expectation for life sciences [110][111] Question: Earnings guidance and margin expectations - Management confirmed that the adjusted EPS guidance reflects a cautious approach given the current environment, with a focus on cost structure improvements [86][89]

Lockheed Martin Corporation (LMT) Q1 2025 Earnings Conference Call April 22, 2025 11:00 AM ET Company Participants Sarah - Conference Call ModeratorMaria Richard-Own - Vice President, Treasurer and Investor RelationsJim Taklett - Chairman, President, and Chief Executive OfficerEvan Scott - Chief Financial Officer Conference Call Participants David Strauss - Analyst, BarclaysBasin Gursky - Analyst, CitiChristine Lewald - Analyst, Morgan StanleyGautam Khanna - Analyst, TD CowanRich Safran - Analyst, SeaportPe ...

Financial Data and Key Metrics Changes - The company reported a 3.8% growth in NOI and a 6.7% increase in normalized FFO per share for Q1 2025 [7][27] - The average term to maturity of the company's debt is over eight years, with only 9% of debt maturing before 2027 compared to the REIT average of 30% [8] - The normalized FFO for Q1 was 83 cents per share, aligning with guidance [27] Business Line Data and Key Metrics Changes - The MH portfolio accounts for approximately 60% of total revenue, with properties maintaining a 94% occupancy rate [9] - Core community-based rental income increased by 5.5% compared to Q1 2024, while annual rent from RV sites grew by 4.1% [27][23] - Transient rent decreased by 9.1% compared to Q1 2024 [28] Market Data and Key Metrics Changes - The company experienced a loss of approximately 170 occupied sites due to hurricanes, impacting occupancy levels [21][22] - The average single-family home prices in key markets like Florida and California significantly exceed the prices of homes in the company's MH communities, providing a competitive advantage [19][20] Company Strategy and Development Direction - The company aims to maintain strong core operations and FFO growth, with a full-year FFO guidance of $3.06 per share [7][34] - The focus remains on enhancing customer engagement through digital marketing and social media, with a significant increase in online leads [13][14] - The company is preparing for the summer season and anticipates strong demand for its properties [15][16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the stability of the business despite external challenges, citing strong demand and limited new supply in the MH and RV markets [17][18] - The company expects a modest increase in occupancy for the remainder of the year, maintaining a consistent demand profile [64] Other Important Information - The company has access to approximately $1 billion in capital from credit lines and ATM programs, ensuring financial flexibility [40] - The insurance premium decreased by approximately 6% year-over-year, with no changes in deductibles or coverage [31][84] Q&A Session Summary Question: Impact of hurricane on MH top line guidance - Management acknowledged that the hurricane impact was significant, resulting in a loss of 176 sites, but noted that demand remains strong with a mark-to-market running at about 14% year-to-date [46][47] Question: Trends in MH occupancy - Management indicated that occupancy was flat to slightly up when excluding hurricane impacts, with a consistent average length of stay of around 10 years [50][56] Question: Canadian customer exposure - Approximately 10% of RV revenue comes from Canadian customers, with no significant changes in behavior impacting guidance [59] Question: Seasonal and transient RV revenue expectations - Management noted that the forecast for seasonal and transient RV revenues is based on reservation pacing, with some properties experiencing headwinds [72][75] Question: Home sales trends - Home sales were down in Q1 due to hurricane impacts, but management remains optimistic about demand moving forward [78] Question: Insurance renewal discussions - The company successfully negotiated a 6% decrease in insurance premiums despite recent storm incidents, maintaining coverage and deductibles [84][86] Question: Annual RV revenue growth - Management explained that the first quarter's performance was impacted by a leap year comparison, and they expect growth to reaccelerate [121][122]